T/FIF, a New Plateau Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : T/FIF, a New Plateau

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: JMarcus who wrote (832)	1/29/2002 1:48:09 PM
From: stomper	of 2243

FWIW, I talked to a perio who runs a well known, high volume office here in Minneapolis. He was ambivalent to Atridox citing the need for refrigeration, mixing and application. He loves Arestin for exactly the opposite reasons. Said it is so nice to be able to step back and grab it off the shelf in the procedure room, contemporaneously...not have to worry about mixing it. He described the difference in clinical efficacy as so nominal to not be worth using in his decision. I'm surprised Arestin hasn't received the ADA seal though. I would think with consumers, this would be a BIG sell for Atridox. -dave

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next